Filter by tags: Liver Clear all tag filters
4 news articles found
The University of Missouri has launched an initiative to build a new, larger research reactor, NextGen MURR. The university's existing MU Research Reactor (MURR) - in operation for more than half a century - is the highest-powered university research reactor in the USA and is currently the country's only producer of certain medical radioisotopes.
- Source: World Nuclear News
- Date: Saturday, 01 April 2023
- Original article: world-nuclear-news.org/Articles/New-isotope-producing-research-reactor-for-Missour
Bruce Power and Kinectrics-Framatome joint venture Isogen are examining the feasibility of producing the medical radioisotope yttrium-90 using the innovative Isotope Production System (IPS) installed in unit 7 at Bruce Power's nuclear power plant in Ontario.
- Source: World Nuclear News
- Date: Wednesday, 29 June 2022
- Original article: world-nuclear-news.org/Articles/Bruce-Power,-Isogen-look-to-build-on-radioisotope
The Dutch medical device company Quirem Medical recently started using the BR2 research reactor at the SCK CEN nuclear research centre for the production of QuiremSpheres, SCK CEN said on 15 June. QuiremSpheres are used for treating liver cancer and consist of small radioactive spheres loaded with holmium-166. In 2020, more than 905,000 people across the world were diagnosed with primary liver cancer, and 830,180 liver cancer patients died. A promising treatment is the use of a therapeutic radioisotope: holmium-166. This radioisotope is injected into the hepatic artery in the form of millions of tiny spheres - each one smaller than a human hair. The holmium spheres, called holmium microspheres, accumulate in the tiniest capillaries of the liver tumours and locally emit their radiation there. The tumours shrink or disappear, while the surrounding healthy liver tissue is spared. Patients with liver cancer for whom surgery is not an option are eligible for this treatment, also known as selective internal radiotherapy (SIRT).
- Source: NEI Magazine
- Date: Friday, 18 June 2021
- Original article: neimagazine.com/news/newsholmium-166-used-to-treat-liver-cancer-8827665
JSC Isotope is to supply isotope products to Brazil under a five-year agreement signed with the National Nuclear Energy Commission (CNEN). According to the agreement, which is in addition to Russia's current weekly supplies to Brazil of molybdenum-99 (Mo-99) and iodine-131, JSC Isotope will supply lutetium-177, yttrium-90, cobalt-57, and sources of ionizing radiation based on iridium-192 and germanium-68/gallium-68 generators.
- Source: World Nuclear News
- Date: Wednesday, 27 December 2017
- Original article: world-nuclear-news.org/Articles/Russia-and-Brazil-extend-cooperation-in-nuclear-me